Applying recommendations for diagnostic disclosure of mild cognitive impairment and dementia: Practical guidance for clinicians.

ABSTRACT: A comprehensive evaluation for cognitive impairment should culminate with the communication of the diagnosis to patients and their care partners. This diagnostic disclosure sets the stage for subsequent care. Diagnostic disclosure for individuals with cognitive impairment due to Alzheimer's disease (AD) or AD-related dementias (ADRD) is particularly nuanced and requires a conscientious approach. Clinicians must assess patients' understanding and appreciation of symptoms, goals for the evaluation, and desire for information. Because AD/ADRD can impact patients' perceptions of their symptoms, it is recommended to include an informant or care partner for this assessment and for future care. Here, we provide guidance for addressing the complexities of AD/ADRD diagnostic disclosure to build cli

SUBMITTER: O'Brien K 

PROVIDER: S-EPMC11772705 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature